日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tumor Debulking in Combination With Chemotherapy in Multiorgan Metastatic Colorectal Cancer: The ORCHESTRA Randomized Clinical Trial

肿瘤减瘤联合化疗治疗多器官转移性结直肠癌:ORCHESTRA随机临床试验

Gootjes, Elske C; Bakkerus, Lotte; Adhin, Anviti A; Zonderhuis, Barbara M; Versteeg, Kathelijn S; Tuynman, Jurriaan B; Meijerink, Martijn R; Haasbeek, Cornelis J A; de Wilt, Johannes H W; Grunhagen, Dirk J; Smit, Ewoud J; Primrose, John M; Bridgewater, John; van Meerten, Esther; de Groot, Jan-Willem B; Hendriks, Mathijs P; Oomen-de Hoop, Esther; Buffart, Tineke E; Verhoef, Cornelis; Verheul, Henk M W

The Keynote-177 Randomized Controlled Trial of First-line PD-1 Blockade for Microsatellite-High or Mismatch Repair-Deficient Advanced Colorectal Cancer: Potential Consequences of the Cross-Over Trial Design and Related Issues

Keynote-177 随机对照试验:一线 PD-1 阻断治疗微卫星高表达或错配修复缺陷型晚期结直肠癌:交叉试验设计的潜在后果及相关问题

Gerritse, S L; van Meerten, E; Duits, A J; Schnog, J B

Brexucabtagene Autoleucel versus Allogeneic Hematopoietic Cell Transplantation in Relapsed and Refractory Mantle Cell Lymphoma

Brexucabtagene Autoleucel 与异基因造血干细胞移植治疗复发难治性套细胞淋巴瘤的比较

Liebers, Nora; Boumendil, Ariane; Finel, Hervé; Edelmann, Dominic; Kobbe, Guido; Baermann, Ben-Niklas; Serroukh, Yasmina; Blaise, Didier; Beelen, Dietrich Wilhelm; Solano, Carlos; Itälä-Remes, Maija; van Meerten, Tom; Choi, Goda; Schmidt, Susanne Anna Christine; Kröger, Nicolaus; Byrne, Jenny; Tudesq, Jean-Jacques; Ossami Saidy, Anna; Nunes, Ana; Siddiqi, Rubina; Baro, Elande; Zheng, Dan; Kloos, Ioana; Dreger, Peter; Sureda, Anna; Glass, Bertram; Dietrich, Sascha

Ex vivo 3D micro-tumour testing platform for predicting clinical response to platinum-based therapy in patients with high-grade serous ovarian cancer.

用于预测高级别浆液性卵巢癌患者对铂类药物治疗的临床反应的体外 3D 微肿瘤测试平台

Koedoot Esmee, van der Meer Dieudonné J, van Altena Anne M, Ceton Lieke J, Sijsenaar Timothy J P, Montero Marta G, Grillet Fanny, Piek Jurgen M J, Bekkers Ruud L M, van der Vorst Maurice J D L, Huijben Auke M T, Baalbergen Astrid, Voogdt Kevin G J A, Verhoeven Loes, Smedts Huberdina P M, Weber Klaus, Hazelbag Hans Marten, Bosse Tjalling, van Persijn-van Meerten Els L, de Kroon Cornelis D, Price Leo, Vader Willemijn, Kroep Judith R, Ottevanger Nelleke P B

T-cell and antibody responses in immunocompromised patients with hematologic malignancies indicate strong potential of SARS-CoV-2 mRNA vaccines

免疫功能低下且患有血液系统恶性肿瘤的患者体内的T细胞和抗体反应表明SARS-CoV-2 mRNA疫苗具有很强的潜力。

Pothast, Cilia R; Hofsink, Quincy; Haggenburg, Sabine; Dijkland, Romy C; Van de Meent, Marian; Van Dijk, Kayleigh; Bhoekhan, Michel S; Haverkate, Nienke J E; Van Meerloo, Johan; Falkenburg, J H Frederik; De Groen, Ruben A L; Broers, Annoek E C; Van Doesum, Jaap A; Van Binnendijk, Rob S; Den Hartog, Gerco; Lissenberg-Witte, Birgit I; Kater, Arnon P; Smits, Gaby P; Wouters, Dorine; Van Leeuwen, Ester M M; Bontkes, Hetty J; Kootstra, Neeltje A; Vogels-Nooijen, Sandra; Van Baarle, Debbie; De Vries, Rory D; Van Meerten, Tom; Mutsaers, Pim G N J; Goorhuis, Abraham; Nijhof, Inger S; Hazenberg, Mette D; Heemskerk, Mirjam H M; Rutten, Caroline E; Study Team, Cobra Kai

K12-ligand-based CAR T cell therapy for CD7-positive T cell malignancies.

基于K12配体的CAR T细胞疗法治疗CD7阳性T细胞恶性肿瘤

Visser Nienke, González-Corrales Macarena, Álvarez-Freile Jimena, Pruis Maurien G, Rockstein Lena, Lourens Harm Jan, Schuringa Jan Jacob, van Meerten Tom, Huls Gerwin, Bremer Edwin

Patients With Relapsed Large B-Cell Lymphoma After 12 Months Have a Similarly Poor Prognosis to Those Relapsing Within 12 Months

大B细胞淋巴瘤复发12个月后的患者,其预后与12个月内复发的患者一样差。

van der Galiën, Hilde T; Kooistra, Hilde A M; Kibbelaar, Robby; Veeger, Nic J G M; Nijland, Marcel; Huls, Gerwin; van Meerten, Tom; van Rijn, Rozemarijn S

Reducing and controlling metabolic active tumor volume prior to CAR T-cell infusion can improve survival outcomes in patients with large B-cell lymphoma

在进行 CAR-T 细胞输注前减少和控制代谢活跃的肿瘤体积可以改善大 B 细胞淋巴瘤患者的生存预后。

Keijzer, Kylie; de Boer, Janneke W; van Doesum, Jaap A; Noordzij, Walter; Huls, Gerwin A; van Dijk, Lisanne V; van Meerten, Tom; Niezink, Anne G H

VISTA drives macrophages towards a pro-tumoral phenotype that promotes cancer cell phagocytosis yet down-regulates T cell responses

VISTA 促使巨噬细胞向促肿瘤表型发展,从而促进癌细胞吞噬作用,同时下调 T 细胞反应

Yusheng Lin #, Ghizlane Choukrani #, Lena Dubbel, Lena Rockstein, Jimena Alvarez Freile, Yuzhu Qi, Valerie Wiersma, Hao Zhang, Karl-Wilhelm Koch, Emanuele Ammatuna, Jan Jacob Schuringa, Tom van Meerten, Gerwin Huls, Edwin Bremer

Impact of debulking therapy on the clinical outcomes of axicabtagene ciloleucel in the treatment of relapsed or refractory large B-cell lymphoma

减瘤治疗对阿西卡巴吉内西罗赛治疗复发或难治性大B细胞淋巴瘤临床疗效的影响

van Meerten, Tom; Kuruvilla, John; Song, Kevin W; Thieblemont, Catherine; Minnema, Monique C; Forcade, Edouard; De Guibert, Sophie; Kersten, Marie José; Mutsaers, Pim Gnj; Wermke, Martin; Zheng, Yan; Xue, Allen; Winters, Joshua N; Nater, Jenny; Shen, Rhine R; Spooner, Clare; Neumann, Frank; Kim, Jenny J; Topp, Max S